Living Donor Protection Act of 2025
Summary
The Living Donor Protection Act of 2025 (S.1552), reported favorably out of committee and on the Senate calendar, prohibits life, disability, and long-term care insurers from discriminating against living organ donors. This removes an underwriting barrier, expands the insured pool, and drives increased transplant volume. Major managed care and insurance stocks have rallied 9-39% in the last 30 days, with this legislation providing a structural tailwind for revenue growth across the sector.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The bill removes discriminatory underwriting against living organ donors, expanding the addressable market for life, disability, and long-term care insurers.
- 2.FMLA expansion for organ donation recovery reduces workforce disruption costs, benefiting employer-sponsored health plans.
- 3.Increased transplant volume from removing insurance barriers creates a downstream tailwind for PBMs and pharmacy revenue.
- 4.Major managed care and insurance stocks have already rallied 6-39% in the last 30 days in anticipation of passage.
Market Implications
The Living Donor Protection Act provides a structural revenue tailwind for life/disability insurers and managed care companies with PBM operations. Current market pricing already reflects the committee advancement, but final passage—likely Q2/Q3 2026—could provide further upside. MetLife ($MET at $80.14) and Lincoln National ($LNC at $37.90) are most directly leveraged as pure-play life/disability carriers, while UnitedHealth ($UNH at $368.30) and CVS ($CVS at $83.57) benefit from the dual insurance+PBM tailwind. Humana ($HUM at $240.92) and Cigna ($CI at $292.13) also gain. The 30-day rally of 9-39% suggests partial pricing, but passage would cement the revenue stream. No negative stock impact is expected from this legislation.
Full Analysis
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
What the bill does
Statutory prohibition on insurers denying coverage, canceling policies, varying premiums, or imposing conditions based solely on living organ donor status, plus FMLA expansion classifying organ donation recovery as a serious health condition.
Who must act
Life, disability, and long-term care insurers operating in the United States, including UnitedHealthcare (UnitedHealth Group's insurance segment) and any underwriting subsidiaries.
What happens
Removes a regulatory barrier to insuring living organ donors, expanding the insurable population by an estimated several thousand donors per year. Reduces premium revenue restriction risk for this cohort and eliminates adverse selection against donors. Also mandates that organ donation recovery be treated as FMLA-qualifying leave, reducing workforce disruption costs for employers and health plans.
Stock impact
UnitedHealth Group's UnitedHealthcare segment sells life, disability, and long-term care products. By eliminating discriminatory underwriting, UNH can now offer coverage to a previously restricted pool, expanding premium revenue. Additionally, Optum's PBM and health services businesses benefit from increased transplant volumes (more medications, lab tests, post-surgical care). The bill is a structural tailwind for revenue growth across both insurance and health services segments.
What the bill does
Statutory prohibition on insurers denying coverage, canceling policies, varying premiums, or imposing conditions based solely on living organ donor status.
Who must act
Life, disability, and long-term care insurers operating in the United States, including Cigna's insurance segments.
What happens
Expands the insurable population by removing a discriminatory underwriting barrier for living organ donors. Increases potential policy issuance and premium revenue from this demographic.
Stock impact
Cigna offers life and disability insurance through its group and individual product lines. The bill allows CI to underwrite this previously restricted population, adding incremental premium revenue. Cigna's PBM (Express Scripts) also benefits from increased transplant-related drug volume, though this is secondary to the direct insurance impact.
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Capping Costs for Consumers Act of 2026
To amend title XVIII of the Social Security Act to provide for certain reforms under the Medicare Advantage program, and for other purposes.
PPLI Abuse Act
Repair Abuses of MSP Payments (RAMP) Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Imposing Sanctions on Those Responsible for Repression in Cuba and for Threats to United States National Security and Foreign Policy
This Executive Order expands the existing national emergency against the Government of Cuba by imposing broad secondary sanctions and asset freezes on foreign persons operating in key sectors of the Cuban economy (energy, defense, metals/mining, financial services, security). It authorizes the Treasury and State Departments to block property and deny entry to individuals and entities involved in repression, corruption, or support for the Cuban government, and empowers Treasury to sanction foreign financial institutions that facilitate transactions for designated persons. The order effectively tightens the U.S. embargo by targeting third-country companies and banks that do business with Cuba.
Promoting Retirement-Savings Access for American Workers by Establishing TrumpIRA.gov
This executive order directs the Treasury Secretary to create a government website (TrumpIRA.gov) by January 1, 2027, that lists private-sector IRAs meeting strict cost and quality criteria (net expense ratios ≤0.15%, no minimums) and promotes the existing federal Saver's Match of up to $1,000. It aims to increase retirement savings access for workers without employer plans, particularly independent contractors and self-employed individuals, by steering them toward low-cost, index-based investment options offered by qualifying financial institutions.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.